Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis

International Immunopharmacology

Volumn 9, Issue 9, 2009, Pages 1079-1086

  Lee, D J ^a   Biros, D J ^a   Taylor, A W ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

MSH; ACTH1 17; Experimental autoimmune uveoretinitis; Plasmid injection; Uveitis

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN[1-17]; GAMMA INTERFERON; MELANOCORTIN 5 RECEPTOR; PLASMID DNA; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GRANULOMA; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PHOTORECEPTOR; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RETINA; RETINA GANGLION CELL; SCORING SYSTEM; T LYMPHOCYTE; UVEORETINITIS;

ADRENOCORTICOTROPIC HORMONE; ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS; AQUEOUS HUMOR; AUTOIMMUNE DISEASES; EYE PROTEINS; FREUND'S ADJUVANT; GENE THERAPY; HUMANS; IMMUNOSUPPRESSION; INJECTIONS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PEPTIDE FRAGMENTS; PLASMIDS; PROTEIN ENGINEERING; RECEPTORS, MELANOCORTIN; RETINA; RETINOL-BINDING PROTEINS; UVEITIS; VACCINES, DNA;

EID: 67649392257     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.05.001     Document Type: Article

References (45)

1. Lerner A.B., and Wright M.R. In vitro frog skin assay for agents that darken and lighten melanocytes. Methods Biochem Anal 8 (1960) 295-307
2. Lee T.H., Lerner A.B., and Buettner-Janusch V. On the structure of human corticotropin (adrenocorticotropic hormone). J Biol Chem 236 (Nov 1961) 2970-2974
3. Lipton J.M., and Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 18 3 (Mar 1997) 140-145
4. Ichiyama T., Zhao H., Catania A., Furukawa S., and Lipton J.M. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol 157 2 (Jun 1999) 359-365
5. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., and Lipton J.M. Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain Res 836 1-2 (Jul 31 1999) 31-37
6. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 161 6 (Sep 15 1998) 2873-2880
7. Li D., and Taylor A.W. Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J Leukoc Biol 84 1 (Jul 2008) 191-198
8. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., and Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci U S A 92 17 (Aug 15 1995) 8016-8020
9. Mason M.J., and Van Epps D. Modulation of IL-1, tumor necrosis factor, and C5a-mediated murine neutrophil migration by alpha-melanocyte-stimulating hormone. J Immunol 142 5 (Mar 1 1989) 1646-1651
10. Catania A., Rajora N., Capsoni F., Minonzio F., Star R.A., and Lipton J.M. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17 4 (1996) 675-679
11. Luger T.A., Kalden D., Scholzen T.E., and Brzoska T. Alpha-melanocyte-stimulating hormone as a mediator of tolerance induction. Pathobiology 67 5-6 (1999) 318-321
12. Taylor A., and Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79 4 (Aug 2001) 358-367
13. Namba K., Kitaichi N., Nishida T., and Taylor A.W. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 72 5 (Nov 2002) 946-952
14. Delgado Hernandez R., Demitri M.T., Carlin A., Meazza C., Villa P., Ghezzi P., et al. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte-stimulating hormone. Neuroimmunomodulation 6 3 (May-Jun 1999) 187-192
15. Milligan E.D., Nguyen K.T., Deak T., Hinde J.L., Fleshner M., Watkins L.R., et al. The long term acute phase-like responses that follow acute stressor exposure are blocked by alpha-melanocyte stimulating hormone. Brain Res 810 1-2 (Nov 9 1998) 48-58
16. Gatti S., Colombo G., Buffa R., Turcatti F., Garofalo L., Carboni N., et al. Alpha-melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74 12 (Dec 27 2002) 1678-1684
17. Nishida T., Miyata S., Itoh Y., Mizuki N., Ohgami K., Shiratori K., et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 4 8 (Aug 2004) 1059-1066
18. Shiratori K., Ohgami K., Ilieva I.B., Koyama Y., Yoshida K., and Ohno S. Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci 45 1 (Jan 2004) 159-164
19. Yin P., Luby T.M., Chen H., Etemad-Moghadam B., Lee D., Aziz N., et al. Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis. Gene Ther 10 4 (Feb 2003) 348-355
20. Han D., Tian Y., Zhang M., Zhou Z., and Lu J. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells. Gene Ther 14 5 (Mar 2007) 383-395
21. Wang C.H., Jawan B., Lee T.H., Hung K.S., Chou W.Y., Lu C.N., et al. Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice. Biochem Biophys Res Commun 322 1 (Sep 10 2004) 153-161
22. Zmijewski M.A., Sharma R.K., and Slominski A.T. Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol 193 1 (Apr 2007) 157-169
23. Ortego J., Wollmann G., and Coca-Prados M. Differential regulation of gene expression of neurotensin and prohormone convertases PC1 and PC2 in the bovine ocular ciliary epithelium: possible implications on neurotensin processing. Neurosci Lett 333 1 (Nov 15 2002) 49-53
24. Ortego J., and Coca-Prados M. Molecular characterization and differential gene induction of the neuroendocrine-specific genes neurotensin, neurotensin receptor, PC1, PC2, and 7B2 in the human ocular ciliary epithelium. J Neurochem 69 5 (Nov 1997) 1829-1839
25. Nakashima M., Nie Y., Li Q.L., and Friedman T.C. Up-regulation of splenic prohormone convertases PC1 and PC2 in diabetic rats. Regul Pept 102 2-3 (Dec 15 2001) 135-145
26. Vindrola O., Mayer A.M., Citera G., Spitzer J.A., and Espinoza L.R. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalin-derived peptides induced by LPS in vivo. Neuropeptides 27 4 (Oct 1994) 235-244
27. LaMendola J., Martin S.K., and Steiner D.F. Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies. FEBS Lett 404 1 (Mar 3 1997) 19-22
28. Kitaichi N., Namba K., and Taylor A.W. Inducible immune regulation following autoimmune disease in the immune-privileged eye. J Leukoc Biol 77 4 (Apr 2005) 496-502
29. Taylor A.W., Streilein J.W., and Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 11 12 (Dec 1992) 1199-1206
30. Taylor A.W. Neuroimmunomodulation and immune privilege: the role of neuropeptides in ocular immunosuppression. Neuroimmunomodulation 10 4 (2002) 189-198
31. Silver P.B., Rizzo L.V., Chan C.C., Donoso L.A., Wiggert B., and Caspi R.R. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci 36 5 (Apr 1995) 946-954
32. Avichezer D., Silver P.B., Chan C.C., Wiggert B., and Caspi R.R. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci 41 1 (Jan 2000) 127-131
33. Egwuagu C.E., Charukamnoetkanok P., and Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 159 7 (Oct 1 1997) 3109-3112
34. Ohta K., Wiggert B., Taylor A.W., and Streilein J.W. Effects of experimental ocular inflammation on ocular immune privilege. Invest Ophthalmol Vis Sci 40 9 (Aug 1999) 2010-2018
35. Taylor A.W., Kitaichi N., and Biros D. Melanocortin 5 receptor and ocular immunity. Cell Mol Biol (Noisy-le-grand) 52 2 (2006) 53-59
36. Taylor A.W. Ocular immunosuppressive microenvironment. Chem Immunol Allergy 92 (2007) 71-85
37. Shen L., Barabino S., Taylor A.W., and Dana M.R. Effect of the ocular microenvironment in regulating corneal dendritic cell maturation. Arch Ophthalmol 125 7 (Jul 2007) 908-915
38. Streilein J.W. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol 74 2 (Aug 2003) 179-185
39. Streilein J.W., Ohta K., Mo J.S., and Taylor A.W. Ocular immune privilege and the impact of intraocular inflammation. DNA Cell Biol 21 5-6 (May-Jun 2002) 453-459
40. Streilein J.W., Okamoto S., Sano Y., and Taylor A.W. Neural control of ocular immune privilege. Ann N Y Acad Sci 917 (2000) 297-306
41. Taylor A.W. Ocular immunosuppressive microenvironment. Chem Immunol 73 (1999) 72-89
42. Nishida T., and Taylor A.W. Specific aqueous humor factors induce activation of regulatory T cells. Invest Ophthalmol Vis Sci 40 10 (Sep 1999) 2268-2274
43. Taylor A.W. Neuroimmunomodulation in immune privilege: role of neuropeptides in ocular immunosuppression. Neuroimmunomodulation 3 4 (Jul-Aug 1996) 195-204
44. Taylor A.W. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol Biol (Noisy-le-grand) 49 2 (Mar 2003) 143-149
45. Taylor A.W., Yee D.G., Nishida T., and Namba K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann N Y Acad Sci 917 (2000) 239-247